Devraj Basu, MD, PhD, FACS

Cancer surgeon-scientist @PennMedicine. Our lab advances therapy for #headandneckcancer #HPV #hnscm. Opinions my own. Patient appointments 2156626972

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@JNCI_Now We defined the gene expression profiles distinguishing HPV+ OPSCCs that are prone to recur after TORS-based therapy. These the tumor-intrinsic and immune-related traits were tightly interrelated and generalizeable to nonsurgical cases as well. https://t.co/YL6vpevdB4

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@ponsdotfamily Excited for this one https://t.co/K2iDnmk1PU

[Pons ܂ Ecosystem @Pons_ecsystm]

https://t.co/NhiCvQtxw9

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@ponsdotfamily Rewards are Imminent https://t.co/K2iDnmk1PU

[Pons ܂ Ecosystem @Pons_ecsystm]

https://t.co/NhiCvQtxw9

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@saturn_credit Registration Opens Soon https://t.co/IAyxA6xdm1

[Saturn | Foundation @Saturn_Fndn]

https://t.co/MTYBZr8His

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@saturn_credit @Curvance @avantprotocol Dont miss out https://t.co/IAyxA6xdm1

[Saturn | Foundation @Saturn_Fndn]

https://t.co/MTYBZr8His

[Arjun Raj @arjunrajlab]

Publishing in our current system involves an enormous amount of wasted mental cycles by some of the smartest people on the planet. Hmm.

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@jerallaire its all safe, thanks to you https://t.co/QZj0QtKBYZ

[Jerremy Fan Circle @jeremeyfans]

https://t.co/wertnMPGsA

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@Arguspad $ARGUS on top https://t.co/sxZyNOPFAN

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@Arguspad $ARGUS on top https://t.co/sxZyNOPFAN

[Arggus Collective @ArguusStudio]

https://t.co/tc1BJeGRyz

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@Arguspad this is massive https://t.co/sxZyNOPFAN

[Arggus Collective @ArguusStudio]

https://t.co/tc1BJeGRyz

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@Arguspad $ARGUS keeps us posted https://t.co/sxZyNOPFAN

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@Arguspad $ARGUS keeps us posted https://t.co/sxZyNOPFAN

[Arggus Collective @ArguusStudio]

https://t.co/tc1BJeGRyz

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@wardenprotocol locked in for this https://t.co/HDuu5Ztc3o

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@wardenprotocol this is huge https://t.co/HDuu5Ztc3o

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@wardenprotocol @base @BNBCHAIN @RobinhoodCrypto excited for this one https://t.co/HDuu5Ztc3o

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@wardenprotocol @base @BNBCHAIN @RobinhoodCrypto all the way up https://t.co/HDuu5Ztc3o

[Devraj Basu, MD, PhD, FACS @BasuLab1]

Well written review by @imrtlee @xrtGenomics et al and an easy read for the non-rad onc, contextualizing differences between the two phase III trials comparing IMRT to IMPT for oropharyngeal cancer. https://t.co/k1Y6SBiyOm

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@JerkGoBoomTV @papertrade_xyz genuinely bullish on this #papertrade

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@JerkGoBoomTV @papertrade_xyz genuinely bullish on this #papertrade

[Devraj Basu, MD, PhD, FACS @BasuLab1]

@paperstrategy_ clearly watching the papertrade clock #paperstrategy_ https://t.co/x4uRRMU9UI